Gene · 246243
Papers1,397
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,397
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential effects of endogenous RNA/DNA hybrids on CRISPR-Cas9-mediated homology-directed repair. | Mol Ther Nucleic Acids | 2026 | 41909468 | PubTator, text mining | PubMed |
| From Genomic Diagnosis to Personalized RNA Medicine: Advances in Next-Generation Sequencing and N-of-1 Antisense Oligonucleotide Therapies for Rare Genetic Diseases. | Genes (Basel) | 2026 | 41898852 | PubTator, text mining | PubMed |
| APOBEC3B regulates HPV replication by inducing R-loop formation and DNA damage. | PLoS Pathog | 2026 | 41871156 | PubTator, text mining | PubMed |
| Alternative splicing in voltage-gated sodium channels: mechanisms, regulatory networks and therapeutic implications. | Ann Med | 2026 | 41869747 | PubTator, text mining | PubMed |
| Phosphorylated DHX9 inhibited the progression of lung adenocarcinoma by regulating R-loops mediated DNA damage. | Int J Biol Markers | 2026 | 41860389 | PubTator, text mining | PubMed |
| Characterisation of Antisense Oligonucleotides by Ion-Pair Reversed-Phase UHPLC-HRMS: Method development using Design of Experiments. | J Mass Spectrom | 2026 | 41856548 | PubTator, text mining | PubMed |
| Epitranscriptomic control of telomere maintenance. | Mol Biol Rep | 2026 | 41854934 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify the EXO1-CAF-1 pathway suppressing R-loop-associated DNA damage. | Nucleic Acids Res | 2026 | 41841497 | PubTator, text mining | PubMed |
| Targeting Expanded CUG and CTG Repeats as a Therapeutic Approach for Myotonic Dystrophy Type 1 (DM1). | ChemMedChem | 2026 | 41797662 | PubTator, text mining | PubMed |
| 2025 FDA TIDES (Peptides and Oligonucleotides) Harvest. | Pharmaceuticals (Basel) | 2026 | 41754785 | PubTator, text mining | PubMed |
| Lipoprotein(a) and Cardiovascular Disease: From Genetic Risk Factor to Therapeutic Target. | Cells | 2026 | 41744758 | PubTator, text mining | PubMed |
| Advancing Gene Therapy for Pancreatitis: From Genetic Insights to Clinical Translation. | Research (Wash D C) | 2026 | 41743849 | PubTator, text mining | PubMed |
| RAD51C-XRCC3 complex regulates FANCM-mediated R-loop resolution to safeguard genome integrity. | Sci Adv | 2026 | 41719405 | PubTator, text mining | PubMed |
| Hemizygous loss of helicases promotes genomic instability and cancer development. | Sci Adv | 2026 | 41719398 | PubTator, text mining | PubMed |
| Two pathogens, one disease: Rethinking leprosy diversification through ancient and modern genomes. | Clin Transl Med | 2026 | 41719146 | PubTator, text mining | PubMed |
| Advances in peptide nucleic acid for targeting RNA and genomic DNA. | Cell Rep Phys Sci | 2026 | 41716301 | PubTator, text mining | PubMed |
| R-loop processing via REXO4-RNaseH1-mediated endo- and exo-cleavage coupling mode prevents genome instability and antitumor immunity. | Sci Adv | 2026 | 41706852 | PubTator, text mining | PubMed |
| Regulation of transcription by R loop-nucleated transcription condensate assembly. | Cell Biosci | 2026 | 41703613 | PubTator, text mining | PubMed |
| DNA damage induced by HIV-1 Vpr triggers epigenetic remodeling and transcriptional programs to enhance virus transcription and latency reactivation. | PLoS Biol | 2026 | 41628238 | PubTator, text mining | PubMed |
| Population Pharmacokinetic/Pharmacodynamic Modeling of Donidalorsen, an Antisense Oligonucleotide in Development for Prophylaxis of Hereditary Angioedema. | CPT Pharmacometrics Syst Pharmacol | 2026 | 41622599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/246243/papers?page=2